Newborn Screening for Gaucher Disease: The New Jersey Experience
International Journal of Neonatal Screening · 02.05.2025 · 11 (2) · 34
DOI: 10.3390/ijns11020034 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Neonatal Screening, online erschienen am 02.05.2025. Verfasst von Caitlin Menello und 18 weiteren Autor:innen. Beteiligte Einrichtung: Section of Biochemical Genetics, Division of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Gaucher disease (GD) is a lysosomal storage disorder (LSD) characterized by glycosphingolipid accumulation. Age of symptomonset and disease progression varies across types of disease. Newborn screening (NBS) for Gaucher disease facilitates early identification of affected individuals and enables pre-symptomatic monitoring with the goal of starting therapies early and improving clinical outcomes. This multi-center study involved New Jersey NBS referral centers. Data regarding initial NBS results, confirmatory testing, diagnosis, and treatment were collected. For patients on therapy, monitoring biomarkers and exam findings are available as of the last clinical evaluation. Between July 2019 and December 2023, 438,515 newborns were screened, with 60 screen-positive cases. Of those positive screens, 19 cases with positive screens did not undergo confirmatory testing due to parental refusal, loss to follow-up, or death; 23 cases were false positives; 14 newborns were diagnosed with GD type I; 2 newborns were diagnosed with suspected type I GD; 2 newborns were diagnosed with GD type II; and 1 case is still pending. Three type I GD patients started enzyme replacement therapy, with the youngest starting at 28 months of age. Post-treatment data are available for these individuals. One type II case was referred to experimental gene therapy, and one was started on ERT. Our results demonstrate that NBS for GD is a valuable public health tool that can facilitate early diagnosis and intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Biochemical Genetics, Division of Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
- Pediatric Genetics & Genomics, Hackensack University Medical Center at Hackensack Meridian Health, Hackensack, NJ 07601, USA.
- Clinical Biochemical Genetics, Atlantic Health System, Morristown, NJ 07960, USA.
- Medical Genetics, St. Joseph's University Medical Center, Paterson, NJ 07503, USA.
- Medical Genetics, Rutgers Health, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA.
ORCID-Profile: Caitlin Menello, Milen Velinov, Can Ficicioglu
Zitieren
APA
Menello, C., Pressley, S., Steffensen, M., Schmidt, S., Pedro, H., Jethva, R., Valdez-Gonzalez, K., Adams, D. J., Gupta, P., King, L. T., Velinov, M., Anderson, S., Bizargity, P., Pletcher, B., Tuite, A., Kresge, C., Day-Salvatore, D. L., Kuehl, R., & Ficicioglu, C. (2025). Newborn Screening for Gaucher Disease: The New Jersey Experience. International Journal of Neonatal Screening, 11(2), 34. https://doi.org/10.3390/ijns11020034
Vancouver
Menello C, Pressley S, Steffensen M, Schmidt S, Pedro H, Jethva R, et al. Newborn Screening for Gaucher Disease: The New Jersey Experience. International Journal of Neonatal Screening. 2025;11(2):34. doi:10.3390/ijns11020034
BibTeX
@article{Menello2025,
author = {Menello, Caitlin and Pressley, Shaney and Steffensen, Madeline and Schmidt, Sarah and Pedro, Helio and Jethva, Reena and Valdez-Gonzalez, Karen and Adams, Darius J and Gupta, Punita and King, Lorien Tambini and Velinov, Milen and Anderson, Sharon and Bizargity, Peyman and Pletcher, Beth and Tuite, Allysa and Kresge, Christina and Day-Salvatore, Debra Lynn and Kuehl, Ryan and Ficicioglu, Can},
title = {Newborn Screening for Gaucher Disease: The New Jersey Experience},
journal = {International Journal of Neonatal Screening},
year = {2025},
volume = {11},
number = {2},
pages = {34},
doi = {10.3390/ijns11020034}
}
EUVIMED